Cogent Biosciences COGT
NASDAQ COGT
$31.66 -0.20 (-0.63%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cogent Biosciences (COGT) FCF Margin (2017 - 2020)

Updated

Cogent Biosciences' FCF Margin was -455.47% in FY2020, down 270.81 percentage points from -184.66% in FY2019.

Analysis

Cogent Biosciences (COGT) FCF Margin (2017 - 2020) Analysis & Trends

From FY2017 onward, Cogent Biosciences has reported FCF Margin for 4 years.

  • FCF Margin shows a three-year change of -135.53 percentage points (FY2017 to FY2020).
  • Per Business Quant data, FCF Margin in earlier years was -184.66% in FY2019 (+154.75 pp), -339.41% in FY2018 (-19.47 pp) and -319.94% in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Cogent Biosciences 5.47 Bn 5.47 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -3,290.71%
Jun 30, 2020 -1,576.52%
Mar 31, 2020 -112.26%
Dec 31, 2019 -55.32%
Sep 30, 2019 -998.53%
Jun 30, 2019 -361.50%
Mar 31, 2019 -378.64%
Dec 31, 2018 -237.06%
Sep 30, 2018 -374.99%
Jun 30, 2018 -498.26%
Mar 31, 2018 -362.88%
Dec 31, 2017 -311.63%
Sep 30, 2017 -281.64%
Jun 30, 2017 -287.54%
Mar 31, 2017 -415.33%
API Access

Cogent Biosciences FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=COGT&period=max&api_key=YOUR_API_KEY